Hematopoietic cell differentiation antigens (CD system 1997). Cancer research relevance

Neoplasma

Volumn 45, Issue 5, 1998, Pages 273-276

  Chorvath B ^a   Sedlak J ^a  

^a INSTITUTE OF CHEMISTRY   (Slovakia)

Author keywords

Antigens; Cancer research; CD system 1997; Hematopoietic cell

Indexed keywords

CADHERIN; CELL ADHESION MOLECULE; CYTOKINE RECEPTOR; DIFFERENTIATION ANTIGEN; LEUKOCYTE ANTIGEN; MONOCLONAL ANTIBODY; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR RECEPTOR; SYNDECAN;

ANTIGEN EXPRESSION; APOPTOSIS; B LYMPHOCYTE; BIOCHEMISTRY; BONE MARROW CELL; BREAST ADENOCARCINOMA; CANCER INVASION; CANCER RESEARCH; CELL ADHESION; CELL LINE; ENDOTHELIUM; HEMATOPOIETIC CELL; HEMATOPOIETIC SYSTEM TUMOR; HUMAN; MELANOMA; METASTASIS; NATURAL KILLER CELL; NONHUMAN; REVIEW; SOLID TUMOR; T LYMPHOCYTE;

EID: 0032421031     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (12)

1. BISWAS, C., ZHANG, Y., DECASTRO, R., GUO, H., NAKAMURA, T., KATAOKA, H., NABESHIMA, K.: The human tumor cell-derived collagenase stimulatory factor (renamed EMMPRIN) is a member of the immunoglobulin superfamily. Cancer Res., 15, 1995, 434-439.
2. CARREY, D.J.: Syndecans: Multifunctional cell-surface co-receptors. Biochem. J., 327, 1997, 1-16.
3. DHODAPKAR, M.V., ABE, E., THEUS, A., LACY, M., LANGFORD, J.K., BARLOGIE, B., SANDERSON, R.D.: Syndecan-1 is a multifunctional regulator of myeloma pathobiology: Control of tumor cell survival, growth, and bone cell differentiation. Blood, 15, 1998, 2679-2688.
4. DHODAPKAR, M.V., KELLY, T., THEUS, A., ATHOTA, A.B., BARLOGIE, B., SANDERSON, R.D.: Elevated levels of shed syndecan-1 correlate with rumour mass and decreased matrix metalloproteinase-9 activity in the scrum of patients with multiple myeloma. Br. J. Haematol., 99, 1997, 368-371.
5. DI ROCCO, F., CARROLL, R.S., ZHANG, J., BLACK, P.M.: Platelet-derived growth factor and its receptor expression in human oligodendrogliomas. Neurosurgery, 42, 1998, 341-346.
6. GUO, H., ZUCKER, S., GORDON, M.K., TOOLE, B.P., BISWAS, C.: Stimulation of matrix metalloproteinase production by recombinant extracellular matrix metalloproteinase inducer from transfected Chinese hamster ovary cells. J. Biol. Chem., 272, 1997, 24-27.
7. JOHNSON, J.P., BAR-ELI, M., JANSEN, B., MARKHOF, K.: Melanoma progression/associated glycoprotein MUC18/MCAM medi ates homotypic adhesion through interaction with a heterophilic ligand. Int. J. Cancer, 73, 1997, 769-774.
8. JOURDAN, M., FERLIN, M., LEGOUFFE, E., HORVATHOVA, M., LIAUTARD, J., ROSSI, J.F., WIJDENES, J., BROCHIER, J., KLEIN, B.: The myeloma cell antigen syndecan-1 is lost by apoptotic myeloma cells. Br. J. Haematol., 100, 1998, 637-646.
9. KATAOKA, H., DECASTRO, R., ZUCKER, S., BISWAS, C.: Tumor cell-derived collagenase-stimulatory factor increases expression of interstitial collagenase, stromelysin, and 72-kDa gelatinase. Cancer Res., 53, 1993, 3154-3158.
10. LEWALLE, J.M., BAJOU, K., DESRUX, J., MAREEL, M., DEJANA, E., NOEL, A., FROIDART, J.M.: Alterations of interendothelial adherent junctions following tumor cell - endothelial cell interaction in vitro. Exp. Cell Res., 237, 1997, 347-356.
11. MATSUMOTO, A., ONO, M., FUJIMOTO, Y., GALLO, R.L., BERNFIELD, M., KOHGO, Y.: Reduced expression of syndecan-1 in human hepatocellular carcinoma with high metastatic potential. Int. J. Cancer, 74, 1997, 482-491.
12. MURAOKA, K., NABESHIMA, K., MURAYAMA, T., BISWAS, C., KOONO, M.: Enhanced expression of a tumor-cell-derived collagenase-stimulatory factor in urothelial carcinoma: Its usefulness as a tumor marker for bladder cancers. Int. J. Cancer, 55, 1993, 19-26.